Tag:
Cetero Research
Latest Headlines
Latest Headlines
Cetero execs look for a silver lining in bankruptcy sale
Pharmalot' s Ed Silverman notes that a group of executives at the company are seeking court permission for a $1.3 million bonus on the sale of the company.
Cetero preps for new owner after filing for bankruptcy protection
Despite filing for Chapter 11 on Monday, Cetero insists it has no plans to cease daily operations or ongoing research.
FDA accusations of 'corrupt' lab practices push Cetero into bankruptcy
Just eight months after the FDA accused employees at the contract research firm Cetero of faking research work for clients, the CRO has filed for bankruptcy protection.
Cetero fires back at scathing FDA accusations
A little more than a day after the FDA issued a scathing report on the CRO Cetero, claiming that employees at its Houston lab had routinely falsified trial data, the clinical research organization
FDA cites 'corrupt' CRO for widespread falsification
Any drug developers which relied on Cetero Research for early-stage research or bioanalytics may have a real problem on their hands. The FDA says that two inspections of its Houston lab in 2010...
